Cargando…
Difficulties in Establishing the Adverse Effects of β-Casomorphin-7 Released from β-Casein Variants—A Review
β-Casomorphin-7 (BCM-7) is a peptide released through the proteolysis of β-casein (β-CN), which is considered a bioactive peptide displaying evidence of promoting the binding and activation of the μ-opioid receptor located in various body parts, such as the gastrointestinal tract, the immune system...
Autores principales: | de Vasconcelos, Marta Liliane, Oliveira, Luisa Maria F. S., Hill, Jeremy Paul, Vidal, Ana Maria Centola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486734/ https://www.ncbi.nlm.nih.gov/pubmed/37685085 http://dx.doi.org/10.3390/foods12173151 |
Ejemplares similares
-
Comparative Effects of Milk Containing A1 versus A2 β-Casein on Health, Growth and β-Casomorphin-7 Level in Plasma of Neonatal Dairy Calves
por: Hohmann, Lisa G., et al.
Publicado: (2020) -
Formation and Degradation of Beta-casomorphins in Dairy Processing
por: Nguyen, Duc Doan, et al.
Publicado: (2015) -
Enhancement of Anti-Tumoral Immunity by β-Casomorphin-7 Inhibits Cancer Development and Metastasis of Colorectal Cancer
por: Mori, Shiori, et al.
Publicado: (2021) -
β-Casomorphin-7 Ameliorates Sepsis-Induced Acute Kidney Injury by Targeting NF-κB Pathway
por: Zhang, ZhiJie, et al.
Publicado: (2019) -
Casomorphins and Gliadorphins Have Diverse Systemic Effects Spanning Gut, Brain and Internal Organs
por: Woodford, Keith Bernard
Publicado: (2021)